"ファイザー" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonPfizer hikes 2025 profit outlook on cost cuts, strong quarterly results - CNBC
Arvinas, Pfizer reworking partnership on ‘Protac’ cancer drug - BioPharma Dive
Arvinas, Pfizer reworking partnership on ‘Protac’ cancer drug BioPharma Dive
Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing - Yah...
Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing Yahoo Finance
Pfizer CEO touts 'extremely productive' talks with Trump administration as MFN pricing, tariff th...
Pfizer CEO touts 'extremely productive' talks with Trump administration as MFN pricing, tariff threats close in Fierce Pharma
US biotech needs government support to match China’s gains, Pfizer CEO says - BioPharma Dive
US biotech needs government support to match China’s gains, Pfizer CEO says BioPharma Dive
Pfizer's embattled obesity program loses another GLP-1 over poor data and strong competition - Fi...
Pfizer's embattled obesity program loses another GLP-1 over poor data and strong competition Fierce Biotech
Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer - The Wall Street Journal
Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer The Wall Street Journal
Pfizer Earnings: Impressive Q2 Results Bolster 2025, but Awaiting More Pipeline Data - Morningstar
Pfizer Earnings: Impressive Q2 Results Bolster 2025, but Awaiting More Pipeline Data Morningstar
Pfizer earnings strong despite Trump’s new 'up to 250%' tariff threat - Euronews.com
Pfizer earnings strong despite Trump’s new 'up to 250%' tariff threat Euronews.com
Call for Applications: Pfizer Independent Medical Education Grant (US) - fundsforNGOs
Call for Applications: Pfizer Independent Medical Education Grant (US) fundsforNGOs
Pfizer predicts higher profit amid cost cuts and pricing pressure from Trump - Financial Times
Pfizer predicts higher profit amid cost cuts and pricing pressure from Trump Financial Times
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance - Business Wire
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance Business Wire
CureVac settles mRNA patent dispute litigation with Pfizer and BioNTech - Reuters
CureVac settles mRNA patent dispute litigation with Pfizer and BioNTech Reuters
Pfizer (PFE) Releases Financial Results for Q2 2025 - Yahoo Finance
Pfizer (PFE) Releases Financial Results for Q2 2025 Yahoo Finance
Pfizer's integrated CMO adopts 'exclusive' mindset as it looks to redefine contract manufacturing...
Pfizer's integrated CMO adopts 'exclusive' mindset as it looks to redefine contract manufacturing partnerships: exec Fierce Pharma
Pfizer's Turnaround Has Truly Started (Earnings Update) - Seeking Alpha
Pfizer's Turnaround Has Truly Started (Earnings Update) Seeking Alpha
Pfizer’s Promising Migraine Treatment Study for Children: A Market Game Changer? - TipRanks
Pfizer’s Promising Migraine Treatment Study for Children: A Market Game Changer? TipRanks
PFE’s Recent Struggles: A Market Perspective - StocksToTrade
PFE’s Recent Struggles: A Market Perspective StocksToTrade
Pfizer raises 2025 profit forecast as cost-cutting program gains traction - Reuters
Pfizer raises 2025 profit forecast as cost-cutting program gains traction Reuters
Pharma prepared to work with Trump on DTC drug sales: Pfizer CEO - BioPharma Dive
Pharma prepared to work with Trump on DTC drug sales: Pfizer CEO BioPharma Dive
Pfizer’s Ongoing Study on COVID-19 Vaccine Effectiveness: Key Insights for Investors - TipRanks
Pfizer’s Ongoing Study on COVID-19 Vaccine Effectiveness: Key Insights for Investors TipRanks
Pfizer’s Promising Pediatric Study on Antibiotic Resistance: A Market Game-Changer? - TipRanks
Pfizer’s Promising Pediatric Study on Antibiotic Resistance: A Market Game-Changer? TipRanks
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance - Yahoo Finance
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance Yahoo Finance
Pfizer Q2 Earnings Preview--Should You Buy, Hold, or Sell? - Yahoo Finance
Pfizer Q2 Earnings Preview--Should You Buy, Hold, or Sell? Yahoo Finance
Pfizer CEO says has spoken with Trump, in ‘productive’ talks with government - Yahoo Finance
Pfizer CEO says has spoken with Trump, in ‘productive’ talks with government Yahoo Finance
S&P 500 Pharma Titan Smashes Earnings Forecasts - Investor's Business Daily
S&P 500 Pharma Titan Smashes Earnings Forecasts Investor's Business Daily
1 Reason to Buy Pfizer (PFE) Stock - The Motley Fool
1 Reason to Buy Pfizer (PFE) Stock The Motley Fool
Pfizer’s Elranatamab Study: A Closer Look at Safety and Efficacy in Multiple Myeloma - TipRanks
Pfizer’s Elranatamab Study: A Closer Look at Safety and Efficacy in Multiple Myeloma TipRanks
Pfizer Raises Profit View as Cost Cuts Offset Poor Sales Growth - Bloomberg.com
Pfizer Raises Profit View as Cost Cuts Offset Poor Sales Growth Bloomberg.com
Pfizer’s Abrysvo Study: Ensuring Vaccine Safety for Older Adults - TipRanks
Pfizer’s Abrysvo Study: Ensuring Vaccine Safety for Older Adults TipRanks
Pfizer’s Observational Study on Multiple Myeloma: Key Insights for Investors - TipRanks
Pfizer’s Observational Study on Multiple Myeloma: Key Insights for Investors TipRanks
Pfizer CEO in Touch With President Over Most Favored Nation Drug Pricing - BioSpace
Pfizer CEO in Touch With President Over Most Favored Nation Drug Pricing BioSpace
Pfizer's tops Q2 on post-pandemic cost cuts, drug revenue - Yahoo Finance
Pfizer's tops Q2 on post-pandemic cost cuts, drug revenue Yahoo Finance
Pfizer’s Ongoing Study on COVID-19 and Influenza: Market Insights and Implications - TipRanks
Pfizer’s Ongoing Study on COVID-19 and Influenza: Market Insights and Implications TipRanks
Pfizer Raises Profit Outlook Despite Uncertainty Over Tariffs, Drug Prices - The Wall Street Journal
Pfizer Raises Profit Outlook Despite Uncertainty Over Tariffs, Drug Prices The Wall Street Journal
Why Shares of Pfizer Soared Today - The Motley Fool
Why Shares of Pfizer Soared Today The Motley Fool
The 3 Things That Matter for Pfizer Now - The Motley Fool
The 3 Things That Matter for Pfizer Now The Motley Fool
Pfizer Pops Despite Looming Pharma Tariffs - Yahoo Finance
Pfizer Pops Despite Looming Pharma Tariffs Yahoo Finance
Pfizer boosts profit estimate, even as the drug giant absorbs tariffs - MarketWatch
Pfizer boosts profit estimate, even as the drug giant absorbs tariffs MarketWatch
Earnings call transcript: Pfizer Q2 2025 earnings beat forecasts, stock rises - Investing.com
Earnings call transcript: Pfizer Q2 2025 earnings beat forecasts, stock rises Investing.com
Pfizer’s Innovative Trial for Multiple Myeloma: A Potential Game-Changer - TipRanks
Pfizer’s Innovative Trial for Multiple Myeloma: A Potential Game-Changer TipRanks
Pfizer’s Rimegepant Study: Assessing Safety in Pregnancy - TipRanks
Pfizer’s Rimegepant Study: Assessing Safety in Pregnancy TipRanks
Pfizer Stock Rises as Earnings Smash Expectations. Guidance Hiked Amid Tariffs. - Barron's
Pfizer Stock Rises as Earnings Smash Expectations. Guidance Hiked Amid Tariffs. Barron's
Pfizer: Earnings Meet Pressure (Rating Upgrade) (NYSE:PFE) - Seeking Alpha
Pfizer: Earnings Meet Pressure (Rating Upgrade) (NYSE:PFE) Seeking Alpha
Pfizer’s Korean Surveillance Study: Ensuring Comirnaty’s Safety Post-Market - TipRanks
Pfizer’s Korean Surveillance Study: Ensuring Comirnaty’s Safety Post-Market TipRanks
Pfizer’s Somatrogon Study in India: A Key Update for Investors - TipRanks
Pfizer’s Somatrogon Study in India: A Key Update for Investors TipRanks
Pfizer and AbbVie Collaborate on Promising Pediatric Antibiotic Study - TipRanks
Pfizer and AbbVie Collaborate on Promising Pediatric Antibiotic Study TipRanks
AMD & Pfizer earnings, ISM services data: What to Watch - Yahoo Finance
AMD & Pfizer earnings, ISM services data: What to Watch Yahoo Finance
Pfizer’s Promising Migraine Study: A Potential Game-Changer for Pediatric Care - TipRanks
Pfizer’s Promising Migraine Study: A Potential Game-Changer for Pediatric Care TipRanks
Pfizer’s ABRYSVO Vaccine Study: A Potential Game-Changer for Infant RSV Protection - TipRanks
Pfizer’s ABRYSVO Vaccine Study: A Potential Game-Changer for Infant RSV Protection TipRanks
Pfizer’s Clinical Study on Drug Interactions in Obesity Treatment: Key Update - TipRanks
Pfizer’s Clinical Study on Drug Interactions in Obesity Treatment: Key Update TipRanks
Pfizer’s Phase 3 Study on Elranatamab: A Potential Game-Changer for Multiple Myeloma - TipRanks
Pfizer’s Phase 3 Study on Elranatamab: A Potential Game-Changer for Multiple Myeloma TipRanks
Pfizer’s New COVID-19 Treatment Study: A Potential Game Changer? - TipRanks
Pfizer’s New COVID-19 Treatment Study: A Potential Game Changer? TipRanks
Pfizer’s Promising Phase 3 Study on Rimegepant for Menstrual Migraine Prevention - TipRanks
Pfizer’s Promising Phase 3 Study on Rimegepant for Menstrual Migraine Prevention TipRanks
Pfizer’s Promising Phase 1 Study on PF-07799933 for Advanced Solid Tumors - TipRanks
Pfizer’s Promising Phase 1 Study on PF-07799933 for Advanced Solid Tumors TipRanks
Pfizer’s New Prostate Cancer Study: A Potential Game-Changer? - TipRanks
Pfizer’s New Prostate Cancer Study: A Potential Game-Changer? TipRanks
Chris Boshoff: Pfizer’s Updates from the Second Quarter - Oncodaily
Chris Boshoff: Pfizer’s Updates from the Second Quarter Oncodaily
Pfizer, Caterpillar and Marriott: Market Movers - Yahoo Finance
Pfizer, Caterpillar and Marriott: Market Movers Yahoo Finance
Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug pri...
Pfizer Pops Despite Looming Pharma Tariffs - The Daily Upside
Pfizer Pops Despite Looming Pharma Tariffs The Daily Upside
Vital Signs: Pfizer's fastest growing drugs - FirstWord Pharma
Vital Signs: Pfizer's fastest growing drugs FirstWord Pharma
Pfizer in Charts: Global Biopharma business revenue rose 10% Y/Y in Q2 (NYSE:PFE) - Seeking Alpha
Pfizer in Charts: Global Biopharma business revenue rose 10% Y/Y in Q2 (NYSE:PFE) Seeking Alpha
Stock Movers: Palantir, Pfizer, Caterpillar - Bloomberg.com
Stock Movers: Palantir, Pfizer, Caterpillar Bloomberg.com
Pfizer raises 2025 profit forecast as cost-cutting gains traction - Yahoo Finance
Pfizer raises 2025 profit forecast as cost-cutting gains traction Yahoo Finance
Pfizer’s Inclacumab Study: Long-term Safety Insights for Sickle Cell Disease - TipRanks
Pfizer’s Inclacumab Study: Long-term Safety Insights for Sickle Cell Disease TipRanks
Pfizer upgrades after stronger Q2 than anticipated - medwatch.com
Pfizer upgrades after stronger Q2 than anticipated medwatch.com
Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win - Reuters
Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win Reuters
Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle (PFE) - Seeking...
Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle (PFE) Seeking Alpha
Pfizer and BioNTech’s New Shingles Vaccine Study: A Potential Game-Changer? - TipRanks
Pfizer and BioNTech’s New Shingles Vaccine Study: A Potential Game-Changer? TipRanks
Pfizer bumps up EPS guidance, factors in some policy thorns - Endpoints News
Pfizer bumps up EPS guidance, factors in some policy thorns Endpoints News
What’s Next For Pfizer Stock After A Solid Q2? - Trefis
Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth - Zacks Investment Research
Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth Zacks Investment Research
Pfizer’s Promising Phase 3 Study on Elranatamab for Multiple Myeloma - TipRanks
Pfizer’s Promising Phase 3 Study on Elranatamab for Multiple Myeloma TipRanks
Stocks making the biggest premarket moves: Pfizer, Eaton, Palantir, Yum and more - CNBC
Stocks making the biggest premarket moves: Pfizer, Eaton, Palantir, Yum and more CNBC
Pfizer rises after earnings beat, boost to full-year profit outlook - Sherwood News
Pfizer rises after earnings beat, boost to full-year profit outlook Sherwood News
Pfizer ups profit forecast as cost cuts begin to take effect - FirstWord Pharma
Pfizer ups profit forecast as cost cuts begin to take effect FirstWord Pharma
Pfizer CEO shares 3 pillars of company's cost-cutting efforts - Yahoo Finance
Pfizer CEO shares 3 pillars of company's cost-cutting efforts Yahoo Finance
Pfizer's Upcoming Earnings and Strategic Innovation in Biopharma: A Deep Dive into Value Potentia...
Pfizer's Upcoming Earnings and Strategic Innovation in Biopharma: A Deep Dive into Value Potential AInvest
Pfizer’s Pediatric Migraine Study: A Potential Game-Changer? - TipRanks
Pfizer’s Pediatric Migraine Study: A Potential Game-Changer? TipRanks
Updated: Pfizer CEO says drugmakers are ready to work with Trump on direct sales program - Endpoi...
Updated: Pfizer CEO says drugmakers are ready to work with Trump on direct sales program Endpoints News
Pfizer’s Latest Study on Enfortumab Vedotin: A Boost for Urothelial Cancer Treatment - TipRanks
Pfizer’s Latest Study on Enfortumab Vedotin: A Boost for Urothelial Cancer Treatment TipRanks
Pfizer’s New Prostate Cancer Study: A Potential Game-Changer - TipRanks
Pfizer’s New Prostate Cancer Study: A Potential Game-Changer TipRanks
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More - BioSpace
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More BioSpace
Buy Pfizer Stock At $24? - Forbes
Buy Pfizer Stock At $24? Forbes
As Pfizer pulls back on obesity asset, Nxera unveils brand new pipeline - FirstWord Pharma
As Pfizer pulls back on obesity asset, Nxera unveils brand new pipeline FirstWord Pharma
Pfizer’s Mevrometostat Study: A New Hope for Challenging Cancers - TipRanks
Pfizer’s Mevrometostat Study: A New Hope for Challenging Cancers TipRanks
Pfizer’s Promising Migraine Study: A Potential Game-Changer for Adolescents - TipRanks
Pfizer’s Promising Migraine Study: A Potential Game-Changer for Adolescents TipRanks
Pfizer: Q2 Earnings Snapshot - San Francisco Chronicle
Pfizer: Q2 Earnings Snapshot San Francisco Chronicle
Moderna Wins UK Patent Battle Against Pfizer and BioNTech - BioSpace
Moderna Wins UK Patent Battle Against Pfizer and BioNTech BioSpace
Pfizer's Global Health Fellows Program: Leveraging Colleagues’ Expertise to Help Improve Healthca...
Pfizer Gets UnCensored About Ulcerative Colitis with Sunny Anderson - Pfizer
Pfizer Gets UnCensored About Ulcerative Colitis with Sunny Anderson Pfizer
Pfizer stock gains on-Q2 beat, guidance raise (PFE:NYSE) - Seeking Alpha
Pfizer stock gains on-Q2 beat, guidance raise (PFE:NYSE) Seeking Alpha
Pfizer’s Phase 3 RSV Vaccine Study: A Potential Game-Changer for Maternal Health - TipRanks
Pfizer’s Phase 3 RSV Vaccine Study: A Potential Game-Changer for Maternal Health TipRanks
Pfizer’s MAGNETISMM-6 Study: A New Horizon in Multiple Myeloma Treatment - TipRanks
Pfizer’s MAGNETISMM-6 Study: A New Horizon in Multiple Myeloma Treatment TipRanks
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (August 2025) - 24/7 Wall St.
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (August 2025) 24/7 Wall St.
Pfizer earnings beat by $0.21, revenue topped estimates - Investing.com
Pfizer earnings beat by $0.21, revenue topped estimates Investing.com
Pfizer CEO says pharma execs discussed Trump’s direct-to-consumer demand - Seeking Alpha
Pfizer CEO says pharma execs discussed Trump’s direct-to-consumer demand Seeking Alpha
Pfizer Stock Surges: Investor’s Dilemma? - StocksToTrade
Pfizer Stock Surges: Investor’s Dilemma? StocksToTrade
Pfizer Q2 2025 Earnings: Strong Growth Amid Challenges - TipRanks
Pfizer Q2 2025 Earnings: Strong Growth Amid Challenges TipRanks